Effect of glutamate transporter EAAT2 gene variants and gray matter deficits on working memory in schizophrenia

详细信息    查看全文

• 作者：S. Poletti^a ; ^b ; ^{poletti.sara@hsr.it" class="auth_mail} ; D. Radaelli^a ; ^b ; M. Bosia^a ; M. Buonocore^a ; A. Pirovano^a ; C. Lorenzi^a ; R. Cavallaro^a ; E. Smeraldi^a ; ^b ; F. Benedetti^a ; ^b
• 关键词：Schizophrenia ; EAAT2 ; Glutamate ; Working memory ; Structural imaging
• 刊名：European Psychiatry
• 出版年：May 2014
• 年：2014
• 卷：29
• 期：4
• 页码：219-225
• 全文大小：880 K

文摘

Glutamate is the major excitatory neurotransmitter in the brain, with up to 40% of all synapses being glutamatergic. An altered glutamatergic transmission could play a critical role in working memory deficts observed in schizophrenia and could underline progressive changes such as grey matter loss throughout the brain. The aim of the study was to investigate if gray matter volume and working memory could be modulated by a genetic polymorphism related to glutamatergic function. Fifty schizophrenia patients underwent magnetic resonance and working memory testing outside of the scanner and were genotyped for rs4354668 EAAT2 polymorphism. Carriers of the G allele had lower gray matter volumes than T/T homozygote and worse working memory performance. Poor working memory performance was associated with gray matter reduction. Differences between the three genotypes are more relevant among patients showing poor performance at the 2-back task. Since glutamate abnormalities are known to be involved in excitotoxic processes, the decrease in cortical thickness observed in schizophrenia patients could be linked to an excess of extracellular glutamate. The differential effect of EAAT2 observed between good and poor performers suggests that the effect of EEAT2 on gray matter might reveal in the presence of a pathological process affecting gray matter.